トランスサイレチンアミロイドーシス（ATTR）の世界市場（～2026年）

• 英文タイトル：Global Transthyretin Amyloidosis (ATTR) Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY04896
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、92ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料はトランスサイレチンアミロイドーシス（ATTR）のグローバル市場について調査・分析したレポートです。種類別（遺伝性ATTR（HATTR）、野生型（WT）ATTR）市場規模、用途別（病院、外来外科センター、診断センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別トランスサイレチンアミロイドーシス（ATTR）の競争状況、市場シェア
・世界のトランスサイレチンアミロイドーシス（ATTR）市場：種類別市場規模 2015年-2020年（遺伝性ATTR（HATTR）、野生型（WT）ATTR）
・世界のトランスサイレチンアミロイドーシス（ATTR）市場：種類別市場規模予測 2021年-2026年（遺伝性ATTR（HATTR）、野生型（WT）ATTR）
・世界のトランスサイレチンアミロイドーシス（ATTR）市場：用途別市場規模 2015年-2020年（病院、外来外科センター、診断センター）
・世界のトランスサイレチンアミロイドーシス（ATTR）市場：用途別市場規模予測 2021年-2026年（病院、外来外科センター、診断センター）
・北米のトランスサイレチンアミロイドーシス（ATTR）市場分析：米国、カナダ
・ヨーロッパのトランスサイレチンアミロイドーシス（ATTR）市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのトランスサイレチンアミロイドーシス（ATTR）市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のトランスサイレチンアミロイドーシス（ATTR）市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのトランスサイレチンアミロイドーシス（ATTR）市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Pfizer、Alnylam Pharmaceuticals、Ionis Pharmaceuticals、Corino Therapeutics、Proclara Bioscience、Arcturus Therapeutics
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Transthyretin Amyloidosis (ATTR) is an autosomal dominant hereditary disease that occurs due to deposition of variant TTR (transthyretin) protein in humans. It is mainly characterized into two main types i.e. Hereditary ATTR (hATTR) and Wild-Type (wt) ATTR. While Hereditary ATTR is caused by point mutations within TTR allele, wild-type ATTR is caused by the misfolding of Wild-Type TTR. Major prevalence of Hereditary ATTR is observed in the 7MM, and this type has been further sub-classified into Familial Amyloidosis Polyneuropathy (FAP) and Familial Amyloidosis Cardiomyopathy (FAC).
United States accounts for highest ATTR Amyloidosis Cases, followed by EU5 (Italy, France, Spain, Germany, UK) and Japan.

Market Analysis and Insights: Global Transthyretin Amyloidosis (ATTR) Market
The global Transthyretin Amyloidosis (ATTR) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Transthyretin Amyloidosis (ATTR) Scope and Market Size
Transthyretin Amyloidosis (ATTR) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Transthyretin Amyloidosis (ATTR) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Pfizer
Alnylam Pharmaceuticals
Ionis Pharmaceuticals
Corino Therapeutics
Proclara Bioscience
Arcturus Therapeutics
…

Market segment by Type, the product can be split into
Hereditary ATTR (HATTR)
Wild-Type (WT) ATTR
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Transthyretin Amyloidosis (ATTR) Revenue
1.4 Market by Type
1.4.1 Global Transthyretin Amyloidosis (ATTR) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Hereditary ATTR (HATTR)
1.4.3 Wild-Type (WT) ATTR
1.5 Market by Application
1.5.1 Global Transthyretin Amyloidosis (ATTR) Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Diagnostic Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Transthyretin Amyloidosis (ATTR) Market Perspective (2015-2026)
2.2 Global Transthyretin Amyloidosis (ATTR) Growth Trends by Regions
2.2.1 Transthyretin Amyloidosis (ATTR) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Transthyretin Amyloidosis (ATTR) Historic Market Share by Regions (2015-2020)
2.2.3 Transthyretin Amyloidosis (ATTR) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Transthyretin Amyloidosis (ATTR) Market Growth Strategy
2.3.6 Primary Interviews with Key Transthyretin Amyloidosis (ATTR) Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Transthyretin Amyloidosis (ATTR) Players by Market Size
3.1.1 Global Top Transthyretin Amyloidosis (ATTR) Players by Revenue (2015-2020)
3.1.2 Global Transthyretin Amyloidosis (ATTR) Revenue Market Share by Players (2015-2020)
3.1.3 Global Transthyretin Amyloidosis (ATTR) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Transthyretin Amyloidosis (ATTR) Market Concentration Ratio
3.2.1 Global Transthyretin Amyloidosis (ATTR) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Transthyretin Amyloidosis (ATTR) Revenue in 2019
3.3 Transthyretin Amyloidosis (ATTR) Key Players Head office and Area Served
3.4 Key Players Transthyretin Amyloidosis (ATTR) Product Solution and Service
3.5 Date of Enter into Transthyretin Amyloidosis (ATTR) Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Transthyretin Amyloidosis (ATTR) Historic Market Size by Type (2015-2020)
4.2 Global Transthyretin Amyloidosis (ATTR) Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Transthyretin Amyloidosis (ATTR) Market Size by Application (2015-2020)
5.2 Global Transthyretin Amyloidosis (ATTR) Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Transthyretin Amyloidosis (ATTR) Market Size (2015-2020)
6.2 Transthyretin Amyloidosis (ATTR) Key Players in North America (2019-2020)
6.3 North America Transthyretin Amyloidosis (ATTR) Market Size by Type (2015-2020)
6.4 North America Transthyretin Amyloidosis (ATTR) Market Size by Application (2015-2020)

7 Europe
7.1 Europe Transthyretin Amyloidosis (ATTR) Market Size (2015-2020)
7.2 Transthyretin Amyloidosis (ATTR) Key Players in Europe (2019-2020)
7.3 Europe Transthyretin Amyloidosis (ATTR) Market Size by Type (2015-2020)
7.4 Europe Transthyretin Amyloidosis (ATTR) Market Size by Application (2015-2020)

8 China
8.1 China Transthyretin Amyloidosis (ATTR) Market Size (2015-2020)
8.2 Transthyretin Amyloidosis (ATTR) Key Players in China (2019-2020)
8.3 China Transthyretin Amyloidosis (ATTR) Market Size by Type (2015-2020)
8.4 China Transthyretin Amyloidosis (ATTR) Market Size by Application (2015-2020)

9 Japan
9.1 Japan Transthyretin Amyloidosis (ATTR) Market Size (2015-2020)
9.2 Transthyretin Amyloidosis (ATTR) Key Players in Japan (2019-2020)
9.3 Japan Transthyretin Amyloidosis (ATTR) Market Size by Type (2015-2020)
9.4 Japan Transthyretin Amyloidosis (ATTR) Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Transthyretin Amyloidosis (ATTR) Market Size (2015-2020)
10.2 Transthyretin Amyloidosis (ATTR) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Transthyretin Amyloidosis (ATTR) Market Size by Type (2015-2020)
10.4 Southeast Asia Transthyretin Amyloidosis (ATTR) Market Size by Application (2015-2020)

11 India
11.1 India Transthyretin Amyloidosis (ATTR) Market Size (2015-2020)
11.2 Transthyretin Amyloidosis (ATTR) Key Players in India (2019-2020)
11.3 India Transthyretin Amyloidosis (ATTR) Market Size by Type (2015-2020)
11.4 India Transthyretin Amyloidosis (ATTR) Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Transthyretin Amyloidosis (ATTR) Market Size (2015-2020)
12.2 Transthyretin Amyloidosis (ATTR) Key Players in Central & South America (2019-2020)
12.3 Central & South America Transthyretin Amyloidosis (ATTR) Market Size by Type (2015-2020)
12.4 Central & South America Transthyretin Amyloidosis (ATTR) Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Transthyretin Amyloidosis (ATTR) Introduction
13.1.4 Pfizer Revenue in Transthyretin Amyloidosis (ATTR) Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Alnylam Pharmaceuticals
13.2.1 Alnylam Pharmaceuticals Company Details
13.2.2 Alnylam Pharmaceuticals Business Overview
13.2.3 Alnylam Pharmaceuticals Transthyretin Amyloidosis (ATTR) Introduction
13.2.4 Alnylam Pharmaceuticals Revenue in Transthyretin Amyloidosis (ATTR) Business (2015-2020)
13.2.5 Alnylam Pharmaceuticals Recent Development
13.3 Ionis Pharmaceuticals
13.3.1 Ionis Pharmaceuticals Company Details
13.3.2 Ionis Pharmaceuticals Business Overview
13.3.3 Ionis Pharmaceuticals Transthyretin Amyloidosis (ATTR) Introduction
13.3.4 Ionis Pharmaceuticals Revenue in Transthyretin Amyloidosis (ATTR) Business (2015-2020)
13.3.5 Ionis Pharmaceuticals Recent Development
13.4 Corino Therapeutics
13.4.1 Corino Therapeutics Company Details
13.4.2 Corino Therapeutics Business Overview
13.4.3 Corino Therapeutics Transthyretin Amyloidosis (ATTR) Introduction
13.4.4 Corino Therapeutics Revenue in Transthyretin Amyloidosis (ATTR) Business (2015-2020)
13.4.5 Corino Therapeutics Recent Development
13.5 Proclara Bioscience
13.5.1 Proclara Bioscience Company Details
13.5.2 Proclara Bioscience Business Overview
13.5.3 Proclara Bioscience Transthyretin Amyloidosis (ATTR) Introduction
13.5.4 Proclara Bioscience Revenue in Transthyretin Amyloidosis (ATTR) Business (2015-2020)
13.5.5 Proclara Bioscience Recent Development
13.6 Arcturus Therapeutics
13.6.1 Arcturus Therapeutics Company Details
13.6.2 Arcturus Therapeutics Business Overview
13.6.3 Arcturus Therapeutics Transthyretin Amyloidosis (ATTR) Introduction
13.6.4 Arcturus Therapeutics Revenue in Transthyretin Amyloidosis (ATTR) Business (2015-2020)
13.6.5 Arcturus Therapeutics Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Transthyretin Amyloidosis (ATTR) Key Market Segments
Table 2. Key Players Covered: Ranking by Transthyretin Amyloidosis (ATTR) Revenue
Table 3. Ranking of Global Top Transthyretin Amyloidosis (ATTR) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Transthyretin Amyloidosis (ATTR) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Hereditary ATTR (HATTR)
Table 6. Key Players of Wild-Type (WT) ATTR
Table 7. Global Transthyretin Amyloidosis (ATTR) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Transthyretin Amyloidosis (ATTR) Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Transthyretin Amyloidosis (ATTR) Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Transthyretin Amyloidosis (ATTR) Market Share by Regions (2015-2020)
Table 11. Global Transthyretin Amyloidosis (ATTR) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Transthyretin Amyloidosis (ATTR) Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Transthyretin Amyloidosis (ATTR) Market Growth Strategy
Table 17. Main Points Interviewed from Key Transthyretin Amyloidosis (ATTR) Players
Table 18. Global Transthyretin Amyloidosis (ATTR) Revenue by Players (2015-2020) (Million US$)
Table 19. Global Transthyretin Amyloidosis (ATTR) Market Share by Players (2015-2020)
Table 20. Global Top Transthyretin Amyloidosis (ATTR) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transthyretin Amyloidosis (ATTR) as of 2019)
Table 21. Global Transthyretin Amyloidosis (ATTR) by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Transthyretin Amyloidosis (ATTR) Product Solution and Service
Table 24. Date of Enter into Transthyretin Amyloidosis (ATTR) Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Transthyretin Amyloidosis (ATTR) Market Size by Type (2015-2020) (Million US$)
Table 27. Global Transthyretin Amyloidosis (ATTR) Market Size Share by Type (2015-2020)
Table 28. Global Transthyretin Amyloidosis (ATTR) Revenue Market Share by Type (2021-2026)
Table 29. Global Transthyretin Amyloidosis (ATTR) Market Size Share by Application (2015-2020)
Table 30. Global Transthyretin Amyloidosis (ATTR) Market Size by Application (2015-2020) (Million US$)
Table 31. Global Transthyretin Amyloidosis (ATTR) Market Size Share by Application (2021-2026)
Table 32. North America Key Players Transthyretin Amyloidosis (ATTR) Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Transthyretin Amyloidosis (ATTR) Market Share (2019-2020)
Table 34. North America Transthyretin Amyloidosis (ATTR) Market Size by Type (2015-2020) (Million US$)
Table 35. North America Transthyretin Amyloidosis (ATTR) Market Share by Type (2015-2020)
Table 36. North America Transthyretin Amyloidosis (ATTR) Market Size by Application (2015-2020) (Million US$)
Table 37. North America Transthyretin Amyloidosis (ATTR) Market Share by Application (2015-2020)
Table 38. Europe Key Players Transthyretin Amyloidosis (ATTR) Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Transthyretin Amyloidosis (ATTR) Market Share (2019-2020)
Table 40. Europe Transthyretin Amyloidosis (ATTR) Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Transthyretin Amyloidosis (ATTR) Market Share by Type (2015-2020)
Table 42. Europe Transthyretin Amyloidosis (ATTR) Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Transthyretin Amyloidosis (ATTR) Market Share by Application (2015-2020)
Table 44. China Key Players Transthyretin Amyloidosis (ATTR) Revenue (2019-2020) (Million US$)
Table 45. China Key Players Transthyretin Amyloidosis (ATTR) Market Share (2019-2020)
Table 46. China Transthyretin Amyloidosis (ATTR) Market Size by Type (2015-2020) (Million US$)
Table 47. China Transthyretin Amyloidosis (ATTR) Market Share by Type (2015-2020)
Table 48. China Transthyretin Amyloidosis (ATTR) Market Size by Application (2015-2020) (Million US$)
Table 49. China Transthyretin Amyloidosis (ATTR) Market Share by Application (2015-2020)
Table 50. Japan Key Players Transthyretin Amyloidosis (ATTR) Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Transthyretin Amyloidosis (ATTR) Market Share (2019-2020)
Table 52. Japan Transthyretin Amyloidosis (ATTR) Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Transthyretin Amyloidosis (ATTR) Market Share by Type (2015-2020)
Table 54. Japan Transthyretin Amyloidosis (ATTR) Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Transthyretin Amyloidosis (ATTR) Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Transthyretin Amyloidosis (ATTR) Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Transthyretin Amyloidosis (ATTR) Market Share (2019-2020)
Table 58. Southeast Asia Transthyretin Amyloidosis (ATTR) Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Transthyretin Amyloidosis (ATTR) Market Share by Type (2015-2020)
Table 60. Southeast Asia Transthyretin Amyloidosis (ATTR) Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Transthyretin Amyloidosis (ATTR) Market Share by Application (2015-2020)
Table 62. India Key Players Transthyretin Amyloidosis (ATTR) Revenue (2019-2020) (Million US$)
Table 63. India Key Players Transthyretin Amyloidosis (ATTR) Market Share (2019-2020)
Table 64. India Transthyretin Amyloidosis (ATTR) Market Size by Type (2015-2020) (Million US$)
Table 65. India Transthyretin Amyloidosis (ATTR) Market Share by Type (2015-2020)
Table 66. India Transthyretin Amyloidosis (ATTR) Market Size by Application (2015-2020) (Million US$)
Table 67. India Transthyretin Amyloidosis (ATTR) Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Transthyretin Amyloidosis (ATTR) Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Transthyretin Amyloidosis (ATTR) Market Share (2019-2020)
Table 70. Central & South America Transthyretin Amyloidosis (ATTR) Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Transthyretin Amyloidosis (ATTR) Market Share by Type (2015-2020)
Table 72. Central & South America Transthyretin Amyloidosis (ATTR) Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Transthyretin Amyloidosis (ATTR) Market Share by Application (2015-2020)
Table 74. Pfizer Company Details
Table 75. Pfizer Business Overview
Table 76. Pfizer Product
Table 77. Pfizer Revenue in Transthyretin Amyloidosis (ATTR) Business (2015-2020) (Million US$)
Table 78. Pfizer Recent Development
Table 79. Alnylam Pharmaceuticals Company Details
Table 80. Alnylam Pharmaceuticals Business Overview
Table 81. Alnylam Pharmaceuticals Product
Table 82. Alnylam Pharmaceuticals Revenue in Transthyretin Amyloidosis (ATTR) Business (2015-2020) (Million US$)
Table 83. Alnylam Pharmaceuticals Recent Development
Table 84. Ionis Pharmaceuticals Company Details
Table 85. Ionis Pharmaceuticals Business Overview
Table 86. Ionis Pharmaceuticals Product
Table 87. Ionis Pharmaceuticals Revenue in Transthyretin Amyloidosis (ATTR) Business (2015-2020) (Million US$)
Table 88. Ionis Pharmaceuticals Recent Development
Table 89. Corino Therapeutics Company Details
Table 90. Corino Therapeutics Business Overview
Table 91. Corino Therapeutics Product
Table 92. Corino Therapeutics Revenue in Transthyretin Amyloidosis (ATTR) Business (2015-2020) (Million US$)
Table 93. Corino Therapeutics Recent Development
Table 94. Proclara Bioscience Company Details
Table 95. Proclara Bioscience Business Overview
Table 96. Proclara Bioscience Product
Table 97. Proclara Bioscience Revenue in Transthyretin Amyloidosis (ATTR) Business (2015-2020) (Million US$)
Table 98. Proclara Bioscience Recent Development
Table 99. Arcturus Therapeutics Company Details
Table 100. Arcturus Therapeutics Business Overview
Table 101. Arcturus Therapeutics Product
Table 102. Arcturus Therapeutics Revenue in Transthyretin Amyloidosis (ATTR) Business (2015-2020) (Million US$)
Table 103. Arcturus Therapeutics Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Transthyretin Amyloidosis (ATTR) Market Share by Type: 2020 VS 2026
Figure 2. Hereditary ATTR (HATTR) Features
Figure 3. Wild-Type (WT) ATTR Features
Figure 4. Global Transthyretin Amyloidosis (ATTR) Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Ambulatory Surgical Centers Case Studies
Figure 7. Diagnostic Centers Case Studies
Figure 8. Transthyretin Amyloidosis (ATTR) Report Years Considered
Figure 9. Global Transthyretin Amyloidosis (ATTR) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Transthyretin Amyloidosis (ATTR) Market Share by Regions: 2020 VS 2026
Figure 11. Global Transthyretin Amyloidosis (ATTR) Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Transthyretin Amyloidosis (ATTR) Market Share by Players in 2019
Figure 14. Global Top Transthyretin Amyloidosis (ATTR) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transthyretin Amyloidosis (ATTR) as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Transthyretin Amyloidosis (ATTR) Revenue in 2019
Figure 16. North America Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed

以下、関連資料のご紹介

アミロイドーシス治療薬の世界市場（～2026年）

Global Amyloidosis Therapeutics Market Insights and Forecast to 2026
MRC2-11QY02417 2020年11月20日 115Pages
当調査資料はアミロイドーシス治療薬のグローバル市場について調査・分析したレポートです。種類別（AG-10、ALN-ANG、ALN-TTRsc02、CAEL-101、カナキヌマブ、その他）市場規模、用途別（ALアミロイドーシス、AAアミロイドーシス、ATTRアミロイドーシス、その他）市場規模、地域別（...

トランスサイレチンの世界市場（～2026年）

Global Transthyretin Market Insights and Forecast to 2026
MRC2-11QY10809 2020年11月25日 116Pages
当調査資料はトランスサイレチンのグローバル市場について調査・分析したレポートです。種類別（AG-10、ALN-TTRsc02、CRX-1008、EDE-1307、イノテルセンナトリウム、その他）市場規模、用途別（家族性アミロイド神経障害、アルツハイマー病、心筋症、神経障害、その他）市場規模、地域別（...

非アルコール性脂肪性肝炎（NASH）の世界市場（～2026年）

Global Nonalcoholic Steatohepatitis (NASH) Market Size, Status and Forecast 2020-2026
MRC2-11QY03996 2020年11月20日 95Pages
当調査資料は非アルコール性脂肪性肝炎（NASH）のグローバル市場について調査・分析したレポートです。種類別（オベチコール酸（OCA）、セロンセルチブ、エムリカサン、GR-MD-02、IMM-124E）市場規模、用途別（病院薬局、オンラインプロバイダー、小売薬局）市場規模、地域別（北米、米国、カナダ、...

市中肺炎（CAP）の世界市場（～2026年）

Global Community Acquired Pneumonia (CAP) Market Size, Status and Forecast 2020-2026
MRC2-11QY11452 2020年11月25日 92Pages
当調査資料は市中肺炎（CAP）のグローバル市場について調査・分析したレポートです。種類別（胸部X線/X線撮影、喀痰グラム染色/培養、血液培養）市場規模、用途別（病院・クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国...

皮膚糸状菌性爪真菌症治療薬（DOT）の世界市場（～2026年）

Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Size, Status and Forecast 2020-2026
MRC2-11QY11621 2020年11月25日 93Pages
当調査資料は皮膚糸状菌性爪真菌症治療薬（DOT）のグローバル市場について調査・分析したレポートです。種類別（局所、経口療法）市場規模、用途別（病院、皮膚科・足病医院、独立薬局、通信販売薬局、ドラッグストア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア...

破壊的行動障害（DBD）の世界市場（～2026年）

Global Disruptive Behavior Disorders (DBD) Market Size, Status and Forecast 2020-2026
MRC2-11QY11684 2020年11月25日 95Pages
当調査資料は破壊的行動障害（DBD）のグローバル市場について調査・分析したレポートです。種類別（行為障害（CD）、反抗挑戦性障害（ODD））市場規模、用途別（病院・クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、...

糖尿病網膜症（DR）の世界市場（～2026年）

Global Diabetic Retinopathy Market Size, Status and Forecast 2020-2026
MRC2-11QY11637 2020年11月25日 152Pages
当調査資料は糖尿病網膜症（DR）のグローバル市場について調査・分析したレポートです。種類別（レーザー手術、コルチコステロイド注射、抗VEGF薬、硝子体切除術）市場規模、用途別（病院、クリニック・研究所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロ...

リソソーム蓄積症（LSD）の世界市場（～2026年）

Global Lysosomal Storage Disease (LSD) Market Size, Status and Forecast 2020-2026
MRC2-11QY12559 2020年11月25日 90Pages
当調査資料はリソソーム蓄積症（LSD）のグローバル市場について調査・分析したレポートです。種類別（脂質代謝異常症、糖タンパク質代謝異常症）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓...

抗体薬物複合体（ADC）の世界市場（～2026年）

Global Antibody Drug Conjugates (ADCs) Market Size, Status and Forecast 2020-2026
MRC2-11QY10862 2020年11月25日 94Pages
当調査資料は抗体薬物複合体（ADC）のグローバル市場について調査・分析したレポートです。種類別（シアトルジェネティクス技術、イミュノジェン技術、イミュノメディクス技術）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシ...

インターロイキン1（IL1）の世界市場（～2026年）

Global Interleukin 1 (IL1) Market Insights and Forecast to 2026
MRC2-11QY01776 2020年11月20日 149Pages
当調査資料はインターロイキン1（IL1）のグローバル市場について調査・分析したレポートです。種類別（APX-002、カナキヌマブ、ディアセレインCR、IR-1000、その他）市場規模、用途別（食道がん、卵管がん、膀胱がん、ベヒサー病、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、...

アミロイドーシス治療薬の世界市場（～2026年） Market Analysis and Insights: Global Amyloidosis Therapeutics Market The global Amyloidosis Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Amyloidosis Therapeutics Scope and Market Size Amyloidosis Therap…
トランスサイレチンの世界市場（～2026年） Market Analysis and Insights: Global Transthyretin Market The global Transthyretin market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Transthyretin Scope and Market Size Transthyretin market is segmented by Type, and by A…
外来手術センターの世界市場（～2026年） Market Analysis and Insights: Global Ambulatory Surgical Centres Market The global Ambulatory Surgical Centres market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Ambulatory Surgical Centres Scope and Market Size Ambulator…
IVD（体外診断）検査の世界市場（～2026年） In-vitro diagnostics (IVD) are used to detect diseases, infections, and conditions and also monitor a person’s state of health and therapeutic procedures by examining specimens derived from the human body such as tissue, blood, stools, urine and the other body fluids. Significant technologies incorp…
子宮がん診断検査の世界市場（～2026年） Uterus a female organ also referred as the womb is located in the lower abdomen. It supports in the fetal development until birth. In North America, the U.S. is expected to be the dominant market for uterine cancer diagnostic testing due to growing incidence of uterine cancer. Market Analysis and In…